Methylmalonic and propionic acidemias: clinical management update
JL Fraser, CP Venditti - Current opinion in pediatrics, 2016 - journals.lww.com
Management guidelines should identify necessary screening for patients with methylmalonic
acidemia and propionic acidemia, and improve anticipatory management of progressive end …
acidemia and propionic acidemia, and improve anticipatory management of progressive end …
Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects
J Baruteau, SN Waddington, IE Alexander… - Journal of inherited …, 2017 - Springer
Over the last decade, pioneering liver-directed gene therapy trials for haemophilia B have
achieved sustained clinical improvement after a single systemic injection of adeno …
achieved sustained clinical improvement after a single systemic injection of adeno …
[HTML][HTML] Propionic acidemia
OA Shchelochkov, N Carrillo, C Venditti - 2016 - europepmc.org
The spectrum of propionic acidemia (PA) ranges from neonatal-onset to late-onset disease.
Neonatal-onset PA, the most common form, is characterized by a healthy newborn with poor …
Neonatal-onset PA, the most common form, is characterized by a healthy newborn with poor …
[PDF][PDF] Liver transplantation for propionic acidemia and methylmalonic acidemia: perioperative management and clinical outcomes
K Critelli, P McKiernan, J Vockley… - Liver …, 2018 - Wiley Online Library
Propionic acidemia (PA) and methylmalonic acidemia (MMA) comprise the most common
organic acidemias and account for profound morbidity in affected individuals. Although liver …
organic acidemias and account for profound morbidity in affected individuals. Although liver …
Liver transplantation in propionic and methylmalonic acidemia: a single center study with literature review
Background Organic acidemias, especially propionic acidemia (PA) and methylmalonic
acidemia (MMA), may manifest clinically within the first few hours to days of life. The classic …
acidemia (MMA), may manifest clinically within the first few hours to days of life. The classic …
Post-transplantation Outcomes in Patients with PA or MMA: A Review of the Literature
S Yap, R Vara, A Morais - Advances in therapy, 2020 - Springer
Introduction Liver transplantation is recognised as a treatment option for patients with
propionic acidemia (PA) and those with methylmalonic acidemia (MMA) without renal …
propionic acidemia (PA) and those with methylmalonic acidemia (MMA) without renal …
Organic acidurias: Major gaps, new challenges, and a yet unfulfilled promise
B Dimitrov, F Molema, M Williams… - Journal of inherited …, 2021 - Wiley Online Library
Organic acidurias (OADs) comprise a biochemically defined group of inherited metabolic
diseases. Increasing awareness, reliable diagnostic workup, newborn screening programs …
diseases. Increasing awareness, reliable diagnostic workup, newborn screening programs …
Methylmalonic acidemia/propionic acidemia–the biochemical presentation and comparing the outcome between liver transplantation versus non-liver transplantation …
Background Most patients with isolated methylmalonic acidemia (MMA)/propionic acidemia
(PA) presenting during the neonatal period with acute metabolic distress are at risk for death …
(PA) presenting during the neonatal period with acute metabolic distress are at risk for death …
Longterm outcome of methylmalonic aciduria after kidney, liver, or combined liverkidney transplantation: the French experience
A Brassier, P Krug, F Lacaille… - Journal of inherited …, 2020 - Wiley Online Library
Organ transplantation is discussed in methylmalonic aciduria (MMA) for renal failure, and
poor quality of life and neurological outcome. We retrospectively evaluated 23 French MMA …
poor quality of life and neurological outcome. We retrospectively evaluated 23 French MMA …
Genetic therapy approaches for ornithine transcarbamylase deficiency
B Seker Yilmaz, P Gissen - Biomedicines, 2023 - mdpi.com
Ornithine transcarbamylase deficiency (OTCD) is the most common urea cycle disorder with
high unmet needs, as current dietary and medical treatments may not be sufficient to prevent …
high unmet needs, as current dietary and medical treatments may not be sufficient to prevent …